NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation (NMTC) Revenue
Annual & quarterly revenue history · segment & region breakdown
NMTC · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsNeuroOne Medical Technologies Corporation trailing twelve-month (TTM) revenue is $0.01B, an increase of 250.35% year-over-year from $0.01B in FY2025.
Revenue trend
2025 – 2010 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-09-30 | $0.01B | +$0.01B | +250.35% |
| 2024-09-30 | $0.00B | +$0.00B | +76.86% |
| 2023-09-30 | $0.00B | +$0.00B | +1040.65% |
| 2022-09-30 | $0.00B | -$0.00B | -3.92% |
| 2021-09-30 | $0.00B | -$0.00B | -90.75% |
| 2020-09-30 | $0.00B | +$0.00B | — |
| 2019-09-30 | $0.00B | +$0.00B | — |
| 2018-09-30 | $0.00B | +$0.00B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | -$0.00B | -100.00% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income NeuroOne Medical Technologies Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
NeuroOne Medical Technologies Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from NeuroOne Medical Technologies Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NMTC revenue · 4 questionsNMTC's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 250.35% year-over-year from $0.01B in FY2025.
▸ Source: FMP · NeuroOne Medical Technologies Corporation SEC filings · GAAP · NeuroOne Medical Technologies Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026